Cases & Deals

  • Home
  • Practices
  • Arsenal Capital Partners acquires HistoGeneX and Caprion Biosciences

Share

Arsenal Capital Partners acquires HistoGeneX and Caprion Biosciences

July 2019

Client(s) Arsenal Capital Partners

Jones Day advised Arsenal Capital Partners on major investments in HistoGeneX and Caprion Biosciences and the subsequent combination of the two businesses. The new partnership creates a global leader in immune monitoring, protein characterization, and tissue pathology solutions for immunotherapy and drug development.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.